V. Petrou

Tay Sachs disease carrier screening in schools: Educational alternatives and cheekbrush sampling

A. Gason, M. Aitken, M. Delatycki, 2005, Genetics in Medicine.

Evaluation of a multi‐disease carrier screening programme in Ashkenazi Jewish high schools

M. Aitken, M. Delatycki, S. Metcalfe, 2010, Clinical genetics.

High school Tay–Sachs disease carrier screening: 5 to 11-year follow-up

M. Delatycki, A. Bankier, E. Levy-Lahad, 2014, Journal of Community Genetics.

Evaluation of a multi‐disease carrier screening programme in Ashkenazi Jewish high schools

M. Aitken, M. Delatycki, S. Metcalfe, 2010, Clinical genetics.

Population‐based carrier screening for cystic fibrosis in Victoria: The first three years experience

M. Delatycki, A. Bankier, L. Ioannou, 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening

J. Emery, M. Delatycki, S. Metcalfe, 2017, Genetics in Medicine.

Factor V Leiden mutation: a contributory factor for cerebral palsy?

D. Reddihough, K. Byron, J. Halliday, 2005, Developmental medicine and child neurology.

Complex phenotypes in the haemoglobinopathies: recommendations on screening and DNA testing

Marcus J Hinchcliffe, R. Lindeman, Meredith Wilson, 2006, Pathology.